NanoVibronix Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Doron Besser
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 2.8yrs |
| Board average tenure | 9.8yrs |
Recent management updates
Recent updates
Most Shareholders Will Probably Find That The Compensation For NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Is Reasonable
Dec 09
NanoVibronix receives extension to satisfy Nasdaq bid price requirement
Oct 19NanoVibronix rises 27% on approval of Uroshield for sale in UK by NHS internal supply chain contract
Sep 23Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely?
Jul 08Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely?
Mar 22Is NanoVibronix (NASDAQ:NAOV) In A Good Position To Deliver On Growth Plans?
Dec 01NanoVibronix: Portable Ultrasonic Therapeutic Devices
Sep 01NanoVibronix (NASDAQ:NAOV) Is In A Good Position To Deliver On Growth Plans
Aug 17CEO
Doron Besser (56 yo)
Dr. Doron Robert Besser, MD, has been Chief Executive Officer of NanoVibronix, Inc. since June 4, 2025 and serves as its Director. Dr. Besser has M.D. from Ludwig-Maximilians-Universität München. He serves...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Financial Officer | 5.1yrs | US$306.22k | 0.00020% $ 9.0 | |
| Chief Medical Officer | 11.7yrs | US$20.54k | no data | |
| CEO & Director | less than a year | no data | no data | |
| Executive VP of Finance | less than a year | no data | no data | |
| Vice President of Sales | no data | no data | no data |
Experienced Management: NAOV's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 10.6yrs | US$43.71k | 0% $ 0 | |
| Independent Chairman of the Board | 9.1yrs | US$185.18k | 0.0034% $ 151.2 | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 10.7yrs | US$35.30k | 0% $ 0 | |
| Director | 9.1yrs | US$424.04k | 0% $ 0 |
Experienced Board: NAOV's board of directors are considered experienced (9.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/18 12:17 |
| End of Day Share Price | 2025/11/18 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
NanoVibronix, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.